Avibactam tomilopil/ceftibuten (Pfizer)

N/A

Report date: 2026/04/21 20:00:18

Base Information

Drug NameAvibactam tomilopil/ceftibuten (Pfizer)
Drug Alias NameCeftibuten Dihydrate/PF-07338233 (Pfizer)PF-07612577CTB+AVP
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitorsBeta Lactamase inhibitors
TargetsBacterial penicillin-binding proteinBeta Lactamase
Therapy Area/IndicationsPyelonephritisUrinary Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsYes Ceftibuten DihydrateAvibactam Tomilopil
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsPyelonephritisUrinary Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A